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Abstract 
Background: Heart rate variability (HRV) is a psychophysiological phenomenon with broad 
implications, providing a widely accessible index of vagal function, underpinning a variety of 
psychological constructs, including the capacity for social engagement and emotion regulation, and 
may predict future morbidity and mortality. However, the lack of reference values for short-term 
HRV indices for participants of both sexes across the age spectrum is a limiting factor. This was the 
objective the present study. Method: Resting electrocardiographic records were obtained from 
13,214 participants (both sexes, 35-74 y) and HRV indices in time and frequency domains (mean ± 
SD) were determined. Results: Final results were based on a subsample of 2,874 non-medicated, 
healthy participants stratified by sex across 10-year age-groupings. Men showed lower heart rate 
(HR, 64 ± 8 bpm vs. 68 ± 8 bpm, P<0.05) and normalized HF (39.4 ± 18.0 n.u. vs. 50.4 ± 18.5 n.u., 
P<0.05) than women, and higher N-N variance (2214 ± 1890 ms2 vs. 1883 ± 1635 ms2, P<0.05), SDNN 
(43.7 ± 17.3 ms vs. 40.3 ± 15.8ms, P<0.05) and LF/HF (2.30 ± 2.68 vs. 1.33 ± 1.82, P<0.05). HR and HF 
(n.u.) were also higher in younger than older women. LF/HF was lower in women compared to men. 
Percentile curves showed almost all HRV indices decreasing with aging. Conclusion: The availability of 
short-term, resting-state HRV reference values in a large sample of healthy and non-medicated 
participants from 35-74 years will provide a valuable tool for use by researchers, clinicians and those 
in the quantified self-community.   
Keywords: Heart rate variability; reference values; autonomic nervous system; cardiovascular 
diseases; frequency domain analysis. 
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Introduction 
Resting-state heart rate variability (HRV) is a psychophysiological phenomenon with broad 
implications. It provides an index of vagal function (Reyes del Paso, Langewitz, Mulder, van, & 
Duschek, 2013),  which supports various psychological functions such as the capacity for social 
engagement (Kemp et al., 2012) and emotion regulation (Williams et al., 2015), and may even predict 
risk for future morbidity and mortality (Hillebrand et al., 2013; May & Arildsen, 2011; Schroeder et 
al., 2003). We have previously reported on the adverse effects of common mental disorders on HRV 
(Brunoni et al., 2013), especially in participants with generalised anxiety disorder (Kemp et al., 2014). 
Others have subsequently shown that changes in HRV precede the appearance of depressive 
symptoms (Jandackova, Britton, Malik, & Steptoe, 2016), consistent with the possibility that 
functioning of the vagus nerve play an aetiological role in depression onset. We have also reported 
that reductions in vagal function – indexed by HRV – may provide a ‘spark’ that initiates a cascade of 
downstream effects, subsequently leading to cognitive impairment (Kemp et al., 2016b). In this 
study, we demonstrated a relationship between HRV and cognitive function, consistent with the 
proposal that HRV may reflect activity within prefrontal-vagal pathways (Thayer, Hansen, Saus-Rose, 
& Johnsen, 2009). We further demonstrated that this relationship was mediated by insulin resistance 
(a marker of type 2 diabetes mellitus) and carotid intima-media thickness (subclinical atherosclerosis) 
(Kemp et al., 2016b), lending further support to the possibility that HRV provides an early indicator of 
ill-health that may have psychological and physiological consequences. Two recently published, 
complimentary models provide a foundation on which much of the HRV literature spanning 
psychological science and epidemiology may be understood. These include the GENIAL model (Kemp, 
Arias, & Fisher, 2017), which describes a theoretical pathway involving genomic and environmental 
influences on the vagus nerve that both supports and is impacted on by social interaction, and plays 
an important regulatory role over allostatic processes that may lead to ill-health and premature 
mortality. The complementary NIACT model refers to neurovisceral integration across a continuum 
of time (Kemp, Koenig, & Thayer, 2017), which like GENIAL, helps to bridge the disciplinary divide 
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from psychological science to epidemiology and public health.  Both models emphasise vagal 
function as a critical mediating factor of health and wellbeing and provide new insights into the 
complex interaction among factors that may lead to longevity or premature mortality.  
A major goal of the present study is to provide reference values for short-term, resting-state 
HRV in a large healthy sample of males and females across different age groups ranging from 35-74 
years. This contribution represents a valuable resource for researchers, clinicians, those in the 
quantitative-self movement, and will support future efforts to understand, identify and predict 
personalised pathways to health and wellbeing. Although reference values for short-term measures 
of HRV in the time and frequency domains have been reported (Nunan, Sandercock, & Brodie, 2010; 
Task Force, 1996), their use remains limited because of the low sample size, variable inclusion 
criteria, a lack of standardisation across methods of data collection and analysis, making it difficult to 
draw comparisons across studies. The more recent review paper (Nunan et al., 2010) reported values 
for short-term HRV based on data in studies on small samples and non-standardised data-collection 
procedures, and none of the reviewed studies had sufficient power to provide normal population 
values as we will do here. Importantly, a variety of factors influence HRV including age (Antelmi et al., 
2004), sex (Koenig & Thayer, 2016; Koenig, Rash, Campbell, Thayer, & Kaess, 2017), medication 
(Kemp et al., 2014; Felber et al., 2006), and ill-health (Buccelletti et al., 2009; Kemp et al., 2010; May 
et al., 2011; Schroeder et al., 2003). A population-based study (Felber et al., 2006) provided normal 
values for long-term HRV measurements, however, since that study was published there is increasing 
interest in use of short-term measures. The sample was also unbalanced between sexes (329 women 
and 170 men) and included a restricted age-range of participants (50-72 years). Recently, another 
study (Sammito & Böckelmann, 2016) in a sample of 695 individuals (aged 20-60 years old) reported 
reference values for time and frequency domain HRV from 24h records. Yet methodological 
problems involving data pre-processing and analysis were detected (Bauer et al., 2017) leading to a 
report on new values (Sammito & Böckelmann, 2017). However, this report is based on longer (24-
hour) ECG records, highlighting a continued need for short-term HRV reference values. 
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Therefore, the aim of the present study was to establish reference values for the most used 
linear indices of short-term HRV collected under standardised and resting-state condition while 
participants were in the supine position. Values were derived from a robust sample of adults (35-74 
years) included in the Longitudinal Study of Adult Health (ELSA-Brasil study). Data were obtained 
from short-term electrocardiographic (ECG) recordings in healthy participants who were medication 
free allowing for future unbiased comparisons with patients from a variety of clinical conditions. 
Given the importance of the HRV metric as well as the increasing interest in short-term measures 
HRV, it is critical that standardized indices from large and representative populations are available.  
 
Method 
Design, participants and procedures 
This study reports on baseline data from the ELSA-Brasil study collected between 2008 and 
2010. A sample of 15,105 civil servants from five public universities and one research institute from 
three Brazilian regions (Northeast, Southeast, and South) were included. The Ethics Committees of 
each institution approved the research protocol and all participants, aged 35–74 years, active or 
retired, signed written consent before participation. Questionnaires were administered by trained 
interviewers, and clinical and laboratory exams were carried out during a scheduled visit to one of 
the six investigation centres. Personal data, demographic characteristics, and all medications under 
regular use were recorded during the interview. Venous blood samples, anthropometric (body 
weight and stature) and hemodynamic data (blood pressure) were collected by trained technicians. 
Blood pressure (BP) was recorded in the morning period, in fasting conditions, and all were 
instructed to avoid consumption of coffee, cigarettes, and alcoholic beverages, as well as not to 
exercise on the day before the exams. BP was recorded at rest in the left arm in the sitting position. 
Measurements were performed using a validated oscillometric device (Omron HEM 705CPINT). 
Three measures were taken at one-minute intervals and the arithmetic mean of the two last readings 
was used to determine the values of systolic, diastolic and mean BP. Biochemical analysis of blood 
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and urine were performed in a central laboratory using commercially available kits (Aquino et al., 
2012). 
Reference values for HRV were generated from a subsample of healthy participants with a 
validated ECG recording. The following exclusion criteria were used: a) current or recent (<4 months) 
pregnancy; b) use of any medication (N=8,892), except oral contraceptives and vitamins; c) self-
report of previous cardiovascular or cerebrovascular disease or cardiac surgery (myocardial 
infarction, N=278; stroke, N=201), including vascular stents (N=268); d) presence of obesity (body 
mass index ≥ 30 kg/m2, N=3,464), diabetes (fasting glycaemia ≥ 126 mg/dL, N=2,970), hypertension 
(blood pressure ≥ 140/90 mmHg, N=5,363), or chronic kidney disease (creatinine ≥ 1.4 mg/dL for 
men, N=341; and ≥ 1.2 mg/dL for women, N=130); and e) Common mental disorders (CMD, 
determined by Clinical Interview Schedule-Revised (CIS-R, (Lewis, Pelosi, Araya, & Dunn, 1992)), in 
which a score ≥ 12 indicated a current CMD (last week), N=4,036). After exclusions, 2,874 apparently 
healthy participants were available for analysis on which reference HRV indices were determined 
(figure 1).  
 
 
ECG records and HRV analysis  
A 10-minute continuous ECG recording was carried out on all participants (sampling rate of 
250 Hz, Micromed, Brazil). Participants were in the supine position in a quiet and temperature-
controlled room (20 – 24°C) while the ECG recording was obtained from a lead with the highest R 
wave amplitude (usually Lead 2). A computer program (WinCardio 4.4) generated the time series of 
R-R intervals, which were sent to a central cardiovascular physiology laboratory for further analyses 
(Mill et al., 2013).  
The R–R series were automatically pre-processed to remove ectopic beats and artefacts. 
Linear interpolation was used to replace removed beats, in accordance with the following criteria: 
each R–R interval was compared to a reference called R–Raverage. The R–Raverage was calculated as the 
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average of the last 10 normal R–R intervals. R–R intervals smaller than 80% of the RRaverage, or greater 
than 120% of the R–Raverage, were considered as ectopic beats and were removed from the R–R series. 
These beats were replaced by linear interpolation. If R–R series were changed by more than 20%, 
they were excluded from analyses (Dantas et al., 2012; Dantas et al., 2015). According to this 
criterion, 3.8% of the ECG records were invalid and excluded from HRV analysis.  
Short-term HRV analyses were carried out on validated and artefact-free R-R series in the 
time and frequency domain using Matlab-customized software (Dantas et al., 2015). For this 
purpose, 5-minute segments were extracted from each 10 min R-R series. Based on criteria of greater 
stability, a standardised 5-minute segment of data was analysed from 2 minutes and 30 seconds until 
7 minutes and 30 seconds. Each segment was pre-processed aiming to remove trends, subtracting 
the values of a linear regression function from the R-R series. Time domain analyses consisted of the 
mean and variance of all normal-to-normal intervals (NN), the standard deviation of all NN intervals 
(SDNN), the percentage of successive R–R intervals differing by more than 50 ms (pNN50), where 
NN50 is the number of pairs of adjacent NN intervals differing by more than 50 ms, and the square 
root of the mean of the sum of the squares of differences between adjacent NN intervals (RMSSD) 
(Task Force, 1996). Frequency domain analyses were performed by autoregressive (AR) modelling 
and Fast Fourier Transform (FFT). The AR model was estimated using the Yule Walker algorithm, 
using a constant model order set as 16 (Dantas et al., 2015; Dantas et al., 2012). For FFT analysis, the 
R-R series were resampled in the time at a sampling rate of 4Hz and the frequency spectrum was 
divided into 1024 points (Task Force, 1996). The very low frequency (VLF, 0–0.04 Hz), low frequency 
(LF, 0.04–0.15 Hz), and high frequency (HF, 0.15–0.40 Hz) were expressed in absolute values and in 
normalized units. Normalization was performed dividing the amount of power of each component by 
total power minus the power of the VLF component (Malliani, Pagani, Lombardi, & Cerutti, 1991; 
Task Force, 1996). The LF/HF ratio was also calculated. 
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Statistical analysis 
Data normality was evaluated by Shapiro-Wilk test and variance homogeneity by Levene’s 
test. Demographic categorical variables were compared between sexes by chi-square test, and 
continuous variables by Wilcoxon-Mann-Whitney test. Next, the participants were categorized into 
four age groups by decades (35-74 years). The mean, standard deviation, and 2.5th, 10th, 25th, 50th, 
75th, 90th, and 97.5th percentiles were calculated for each variable. A one-way ANOVA across age 
groups and a two-way ANOVA (including age and sex factors allowing for the interaction between 
age and sex to be determined) were carried out on HRV. Post-hoc tests were conducted using 
Fisher’s protected least-significant difference (LSD) method. Quantile regression was used to 
estimate the percentiles (from 2.5th to 97.5th) of the HRV indices by age, and curves were generated 
for each HRV variable. In the body of the text, values are shown as mean ± SD. Comparisons were 
considered significant only when P was < 0.05. All statistics analyses were carried out with Stata 
12.0/SE.  
 
Results 
Demographic characteristics of the participants (N=2,874) are shown in table 1. As expected, 
most of the participants were white, with medium to high level of education and non-smokers. In the 
entire group, 12.9% were current smokers, 23.7% were former smokers, and 63.3% never smoked. 
The proportion of current smokers were slightly higher in men than in women (14.1 vs. 11.4%; 
P<0.001). Characteristics of the sample are shown in table 2. Except for age and total cholesterol, all 
the other variables were significantly different between sexes. 
Time and frequency domain analyses (table 3 and 4, respectively) show differences in age on 
most HRV indices, such that HRV was higher in younger than in older groups. However, there were 
no differences for heart rate, normalized LF, and LF/HF ratio.  
Comparing both sexes (supplementary tables S1 and S2), men displayed lower mean heart 
rate (64 ± 8 bpm vs. 68 ± 8 bpm, P<0.05) and normalized HF (39.4 ± 18.0 n.u. vs. 50.4 ± 18.5 n.u., 
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P<0.05) than women, but higher N-N variance (2214 ± 1890 ms2 vs. 1883 ± 1635 ms2, P<0.05), SDNN 
(43.7 ± 17.3 ms vs. 40.3 ± 15.8ms, P<0.05), VLF (1021.4 ± 1033.2 ms2 vs. 832.1 ± 821.4 ms2, P<0.05), 
absolute LF (580.3 ± 608.9 ms2 vs. 385.6 ± 443.5 ms2, P<0.05), normalized LF (56.3 ± 19.2 n.u. vs. 43.7 
± 19.0 n.u., P<0.05), and LF/HF ratio (2.30 ± 2.68 vs. 1.33 ± 1.82, P<0.05) in AR analyses. Similar 
differences between sexes were observed in FFT analyses (supplementary table S4). Considering the 
interaction between age and sex (supplementary tables S1, S2, and S4), significant differences were 
observed in heart rate, NN variance, SDNN, VLF (ms2), LF (ms2), HF (ms2), LF (n.u.), HF (n.u.) and LF/HF 
ratio. NN variance, SDNN, pNN50 and RMSSD, LF (ms2), HF (ms2), HF (n.u.) were higher in younger 
participants of both sexes. Heart rate, HF (ms2), and HF (n.u.) were higher in younger than older 
women.  LF/HF ratio was lower in women compared to men. 
Figures 2 and 3 show the changes of the HRV indices in percentiles as a function of age. It is 
noteworthy that almost all HRV indices decrease as the age increases in both time and frequency 
domain.  While the LF/HF ratio (figure 2) determined using the AR method tends to decrease slightly 
(median or percentile 50) over age, LF/HF ratio increases when determined using FFT (supplementary 
figure S1). This fact occurs because in AR analyses the fall in LF component (absolute and normalized) 
is higher than that observed in HF component. Thus, the ratio tends to be reduced over age. On the 
other hand, in FFT analyses the reduction in LF component tends to be less than for the HF 
component. In fact, normalized LF increases while normalized HF decreases slightly over age, and 
LF/HF ratio become it higher (supplementary table S4). 
Additional analyses were performed by age range and ethnic groups (supplementary tables 
S5 and S6) and clinical conditions such as hypertension (supplementary tables S7 and S8), and mental 
disorder (tables S9 and S10). Considering individuals of the same race, younger individuals (35-44 
years) showed higher values of N-N variance and SDNN. Differences in between-race comparisons 
were noticed for time (N-N variance and SDNN) and frequency domain analyses (Ln LF ms2). Young 
indigenous showed the highest values of N-N variance and SDNN, while white subjects showed 
higher values of Ln LFms2 than brown subjects. Asiatic subjects showed lower Ln LF ms2 than brown 
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and white subjects. For hypertensive participants no significant difference was observed among 
subjects of different age ranges. In participants with mental disorders there was a noticeable effect 
of age in time domain (N-N variance, SDNN, pNN50, RMSSD) and frequency domain (VLF, absolute LF 
and HF) indices, in that all were decreased in older subjects. 
Finally, the analyses were performed in all individuals of the sample (supplementary tables 
S11 and S12). The same differences described above for apparently healthy individuals were also 
kept when were carried out without exclusion, highlighting the extensive impacts of gender and age. 
Again, most HRV variables in time and frequency domains decreased over age. The LF/HF ratio 
increased with age in both women and men, although in the older age-range values were lower in 
men.  
 
Discussion 
Although the need for HRV reference values in large population studies was identified many 
years ago by the Task Force of the European Society of Cardiology and the North American Society 
for Pacing and Electrophysiology (Task Force, 1996), few studies have addressed this need in relation 
to short-term HRV indices. Considering the broad interest in HRV spanning fields as diverse as 
psychological science and epidemiology, the hitherto lack of valid, short-term reference values is 
surprising. Therefore, our research will provide an important resource to researchers and clinicians 
as well as those involved in the quantified-self community. Our study also provides an important 
resource for personalised healthcare planning considering previously reported relationships between 
HRV and health behaviours, capacity to regulate emotion, cognitive flexibility, social functioning, 
mental and physical health, and future mortality (Kemp, Arias, & Fisher, 2017; Kemp, Koenig, & 
Thayer, 2017). To our knowledge, the present study is the first to provide reference values for short-
term resting-state HRV measurements in a large, healthy and medication-free sample.  
Reference values of HRV presented here were obtained from a large cohort study of the 
Brazilian population. HRV indices vary greatly among subjects as we demonstrate here. Autonomic 
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modulation is age-related: a major age-related change occurs primarily as a reduction in vagal 
modulation, while sympathetic modulation decreases at a slower rate (Antelmi et al., 2004; Lipsitz, 
Mietus, Moody, & Goldberger, 1990). Results of the present work are consistent with these earlier 
findings: almost all HRV variables were shown to decrease with age. Moreover, when the analyses 
were performed by sex, it was noticed that men show higher variance (mathematically equal to total 
power), LF (absolute and normalized), and lower HF (mainly the normalized) than women. Identic 
results were previously reported (Koenig et al., 2016).  The possibility that the values established in 
this study are consistent with healthy individuals from other regions, such as North America, Europe 
or Asia cannot be dismissed, and we eagerly await for the publication of reference values from other 
large cohort studies around the world. However, it is important to reinforce the fact that many 
variables may impact on such comparisons.  
Take for example ethnic factors, which exert considerable effects on HRV, as we have 
demonstrated previously (Kemp et al., 2016a). We have demonstrated previously that ‘Black’ and 
‘Brown’ individuals display higher HRV than ‘Whites’, findings similar to those reported from North 
American samples (Hill et al., 2015). Extending beyond between-group differences, we further 
hypothesised (Kemp et al., 2016a) that black individuals may suffer repeated experience of 
discrimination, and that this discrimination might mediate the relationship between race and HRV, 
and this hypothesis was supported. We concluded that higher HRV in ‘Blacks’ and ‘Browns’ may 
reflect a sustained compensatory psychophysiological response to the adverse effects of 
discrimination.  
While chronic reductions in a broad range of HRV indices in comparison to healthy controls – 
reference values for which we present here – are usually considered to reflect ill-health, there has 
been controversy over the interpretation of the LF component. Historically, the LF component has 
been considered as a marker of sympathetic nervous system function (Malliani et al., 1991; Montano 
et al., 1994; Rimoldi et al., 1990), especially when it has evaluated in normalized units, while others 
interpreted it as an unspecific index of sympathetic and parasympathetic activity (Berntson et al., 
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1997; Task Force, 1996; Akselrod et al., 1981). More recently, others have argued that this 
component – as with other HRV indices – predominantly reflects parasympathetic nervous system 
activity (Reyes del Paso et al., 2013). We have provided reference values for both these variables as 
new insights may emerge in future work.  
Our study has a number of strengths. First, our study provides reference values for males and 
females in a large sample of participants, once all potential confounding was addressed. Participants 
were removed from analysis if they presented with hypertension (Schroeder et al., 2003), diabetes 
(May et al., 2011), coronary heart disease and myocardial infarction (Buccelletti et al., 2009), obesity 
(Karason, Molgaard, Wikstrand, & Sjostrom, 1999), kidney disease (Furuland, Linde, Englund, & 
Wikstrom, 2008) and stroke (Graff et al., 2013) . Participants on medications including angiotensin 
converting enzyme inhibitors, antiarrhythmics, beta blockers, diuretics and sympathetic agonists 
(Felber et al., 2006), antidepressants (Kemp et al., 2010; Kemp et al., 2014), were also excluded from 
the present analysis. Therefore, analyses were conducted on a robust sample of healthy adults 
allowing for reference values by sex and age across four decades to be determined.  
Second, we provide reference values based on two different methods, the FFT and the AR 
model, as described in international guidelines (Task Force, 1996). While FFT has been widely used 
due to algorithmic simplicity, the AR method has smoother spectral components and provides a 
more precise estimation of power spectral density even when short records are used (Task Force, 
1996). Although there is a need to verify the complexity of the chosen model (that is, the order of the 
model), there is evidence (Dantas et al., 2012) demonstrating that model orders from 9 to 25 
produce similar results. According to Taskforce (1996), results of FFT analyses are comparable to 
those of AR (Task Force, 1996), although more recent work is characterised by disagreement in adult 
populations (Silva et al., 2009) and even in 5-month-old infants (Poliakova et al., 2014). There are 
some possible explanations for these discrepancies including pre-processing steps, such as 
interpolation and detrending, as well as the processing itself. Firstly, according to a previous study 
(Poliakova et al., 2014), AR modelling is based on use of the most significant peaks, whereas FFT 
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tends to include all the components within a frequency band, and therefore, the tails of neighbouring 
components might be assigned into different bands by the FFT and AR approach. Moreover, 
discriminative capacity of FFT has been shown to be directly proportional to the record duration 
(Poliakova et al., 2014; Task Force, 1996). Thus, the AR method may provide a better resolution when 
short data frames are used (Kay & Marple, 1981; Poliakova et al., 2014; Task Force, 1996), and this 
may explain the small differences that we observed here between AR and FFT results.  
Our study also has a number of limitations. First, the ECG evaluations on our participants 
were performed by using a digital electrocardiograph with 250 Hz of sampling rate. When the study 
was started in 2008, the technical specification of the used device was based on recommendations of 
international guidelines (Task Force, 1996). Although devices with higher sampling rates (> 1000 Hz) 
are available today, data from recent studies (Ellis, Zhu, Koenig, Thayer, & Wang, 2015; Mahdiani, 
Jeyhani, Peltokangas, & Vehkaoja, 2015) have shown that electrocardiographs with lower sampling 
rate (<100 Hz) might even be used without affecting HRV indices significantly. Second, we did not 
collect data on respiration rate or tidal volume, which may influence estimates of HRV. Thus, if we 
had performed the breathing control, spectral results, mainly the HF power (Driscoll & Dicicco, 2000), 
could have been quite different to those shown here. Nevertheless, we suggest that spontaneous 
respiration conditions are more comparable to clinical settings. Therefore, the reference values 
generated in our study are likely to be similar to those obtained in the clinical settings allowing better 
comparison with patient groups. We further note that the root mean square of successive 
differences, unlike frequency- based measures, may actually be more robust to changes in breathing 
patterns (Penttilä et al., 2001). Finally, the present work focuses on linear HRV indices only. 
Therefore, it will be necessary to describe non-harmonic and nonlinear components in future work 
once the underlying mechanisms are better understood.  
In conclusion, we provide – for the first time – reference values along with percentile curves 
for major short-term resting-state HRV indices across age and sex in a large, healthy, and medication-
free population allowing for unbiased comparisons in future work. These data provide a foundation 
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for reliable interpretation of HRV collected in research and clinical settings, and may also be of 
interest to those in the quantified-self community. There is now a need for longitudinal population-
based studies to identify HRV thresholds for different age-groups beyond which adverse downstream 
psychological and physiological may arise.    
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Table 1 – Demographic characteristics of the participants 
 All (N)  Men (N) Women (N) 
Pearson  
chi-square P 
Age range (years)      
  35-44 982 593 (35.3%) 389 (32.6%) 
2.78 0.43 
  45-54 1,252 719 (42.8%) 533 (44.6%) 
  55-64 536 305 (18.2%) 231 (19.3%) 
  65-74 104 63 (3.7%) 41 (3.4%) 
Race/ethnicity      
  Black 381 213 (12.8%) 168 (14.3%) 
14.72 0.005 
  Brown 859 523 (31.5%) 336 (28.6%) 
  White 1,491 871 (52.5%) 620 (52.7%) 
  Asiatic 82 35 (2.1%) 47 (4.0%) 
  Indigenous 22 17 (1.0%) 5 (0.43%) 
Education level      
  <8 years 122 102 (6.1%) 20 (1.7%) 55.22 <0.001 
  8-11 years 1,140 699 (41.6%) 441 (36.9%)   
  ≥12 years 1,612 879 (52.3%) 733 (61.4%)   
 Smoking status      
  Current 371 237 (14.1%) 134 (11.2%) 
23.67 <0.001   Past 683 441 (26.2%) 242 (20.2%) 
  Never 1,820 1,002 (59.6%) 818 (68.5%) 
Comparisons were performed with chi-square test. 
 
 
 
 
Table 2- Characteristics of the participants 
 All  (N=2,871) Men (N=1,680) Women (N=1,191) P 
Age (years old) 47 (11) 47 (10) 47 (11) 0.2508 
Height (cm) 167.3 (14.1) 172.6 (9.6) 159.3 (8.3) < 0.0001 
Body weight (kg) 68.7 (16.2) 74.1 (13.6) 61.15 (12.05) < 0.0001 
Body mass index (kg/m²) 24.6 (4.1) 25.0 (3.9) 24.1 (4.4) < 0.0001 
Waist circumference (cm) 85.7 (13.7) 89.5 (11.5) 80.4 (11.8) < 0.0001 
Systolic blood pressure (mmHg) 115 (17) 119 (16) 109 (16) < 0.0001 
Diastolic blood pressure (mmHg) 72 (13) 75 (12) 69 (11) < 0.0001 
Glycaemia (mg/dL) 102 (12) 104 (11) 100 (11) < 0.0001 
Creatinine (mg/dL) 0.90 (0.30) 1.00 (0.20) 0.80 (0.20) < 0.0001 
Total cholesterol (mg/dL) 211 (52) 210 (51) 212 (52) 0.3381 
HDL (mg/dL) 54 (18) 50 (15) 61 (19) < 0.0001 
LDL (mg/dL) 130 (42) 132 (41) 128 (43) 0.0089 
Triglycerides (mg/dL) 101 (74) 115 (85) 86 (55) < 0.0001 
Values are median and interquartile range (75-25). Comparisons between sexes were performed by 
Wilcoxon-Mann-Whitney test. 
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Table 3 - Time domain analysis 
 Percentiles 
  
Age range 
 (years) N 
P 
ANOVA Mean SD 2.5 10 25 50 75 90 97.5 
Heart 
rate 
(bpm) 
  
35-44 982 
0.2429 
66 9 50 54 60 66 72 77 86 
45-54 1252 65 8 51 55 60 65 71 76 83 
55-64 536 65 8 51 56 60 65 70 75 82 
65-74 104 65 9 46 55 59 64 72 78 85 
N-N 
Variance 
(ms2) 
  
35-44 982 
0.0000 
2378 1931 439 727 1145 1844 2966 4841 7484 
45-54 1252 1995 ** 1644 360 544 882 1471 2583 4036 6685 
55-64 536 1769 ** 1748 223 480 759 1249 2120 3435 7142 
65-74 104 1804 ** 2046 221 380 619 1062 2031 4536 9101 
SDNN  
(ms) 
  
35-44 982 
0.0000 
45.7 17.0 21.0 27.0 33.8 42.9 54.5 69.6 86.5 
45-54 1252 41.6 ** 16.2 19.0 23.3 29.7 38.3 50.8 63.5 81.8 
55-64 536 38.7 ** 16.5 14.9 21.9 27.6 35.3 46.0 58.6 84.5 
65-74 104 37.9 ** 19.2 14.9 19.5 24.9 32.6 45.1 67.3 95.4 
pNN50 
(%) 
  
35-44 982 
0.0000 
14.0 15.4 0.0 0.4 2.2 8.0 20.6 37.2 55.1 
45-54 1252 10.0 ** 12.9 0.0 0.0 0.9 4.7 14.1 28.4 47.1 
55-64 536 7.2 ** 11.1 0.0 0.0 0.6 2.7 8.4 21.3 40.4 
65-74 104 7.3 ** 13.2 0.0 0.0 0.3 1.7 8.9 21.9 60.6 
RMSSD 
(ms) 
  
35-44 982 
0.0000 
34.9 17.5 12.1 17.0 23.1 31.0 42.4 58.4 81.2 
45-54 1252 30.0 ** 15.6 10.0 13.8 19.1 26.6 37.1 50.2 69.4 
55-64 536 26.7 ** 15.3 9.5 12.6 17.5 23.1 31.9 44.0 67.5 
65-74 104 27.7 ** 23.6 7.4 10.3 15.0 21.1 31.6 48.8 115.7 
Comparisons between means performed by one-way ANOVA followed by Fisher’s LSD multiple 
comparisons. Significant differences against 35-44 age range: ** - P<0.01. 
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Table 4 – Autoregressive frequency domain analysis 
       Percentiles 
  
Age range 
 (years) N 
P 
ANOVA Mean SD 2.5 10 25 50 75 90 97.5 
VLF 
(ms2) 
  
35-44 982 
0.0326 
1009.2 934.8 108.5 247.1 397.4 731.5 1258.5 2168.7 3654.4 
45-54 1252 920.5 * 936.5 113.4 207.6 346.8 642.3 1153.3 1986.3 3367.3 
55-64 536 900.8 * 1051.1 83.6 180.7 346.6 615.7 1115.8 1900.3 3375.9 
65-74 104 800.9 * 819.3 100.7 151.5 275.1 580.9 1024.3 1557.8 4201.8 
LF 
(ms2) 
  
35-44 982 
0.0000 
594.8 582.3 52.2 121.3 222.8 423.8 738.5 1255.2 2194.8 
45-54 1252 487.7 ** 538.7 36.7 83.5 153.1 311.3 593.8 1080.3 2069.6 
55-64 536 387.1 ** 525.5 21.5 54.5 111.8 216.1 429.5 926.2 1733.3 
65-74 104 319.8 ** 452.2 7.9 34.2 89.4 164.3 318.3 726.0 2314.3 
HF 
(ms2) 
  
35-44 982 
0.0000 
575.5 667.6 41.4 94.0 182.7 343.6 700.4 1328.5 2637.4 
45-54 1252 410.8 ** 491.6 23.7 61.1 117.3 257.5 495.7 930.5 1823.6 
55-64 536 325.9 ** 487.3 27.3 54.7 103.5 201.1 373.0 673.8 1510.3 
65-74 104 383.3 ** 684.2 13.3 35.8 67.8 149.6 358.5 949.1 3439.6 
LF 
(n.u.) 
  
35-44 982 
0.0106 
50.8 19.9 13.7 25.3 35.1 50.7 66.0 76.6 86.8 
45-54 1252 52.3 20.3 13.5 23.7 37.4 53.3 68.0 78.6 87.7 
55-64 536 49.6 20.0 13.1 23.1 33.9 49.4 65.0 75.9 86.4 
65-74 104 47.5 21.8 8.2 17.8 31.4 46.4 64.3 78.6 90.3 
HF (n.u.) 
  
35-44 982 
0.0482 
45.1 19.2 10.1 20.3 30.3 44.9 60.3 70.7 80.9 
45-54 1252 42.9 ** 19.2 10.0 18.1 28.2 41.9 57.0 70.4 80.6 
55-64 536 44.3 18.0 11.7 20.9 30.1 43.9 58.2 67.9 79.6 
65-74 104 45.1 20.3 8.1 17.6 28.0 46.1 60.8 72.3 81.2 
LF/HF 
  
35-44 982 
0.1685 
1.86 2.42 0.17 0.37 0.58 1.12 2.17 3.74 8.13 
45-54 1252 2.01 2.48 0.18 0.35 0.66 1.24 2.40 4.23 8.66 
55-64 536 1.74 2.18 0.19 0.34 0.59 1.08 2.09 3.48 7.39 
65-74 104 1.91 2.60 0.14 0.28 0.52 1.03 2.39 4.46 11.73 
Ln LF (ms2) 
 
35-44 982 
0.0000 
5.99 0.94 3.96 4.80 5.41 6.05 6.60 7.14 7.69 
45-54 1252 5.71 ** 1.05 3.61 4.43 5.04 5.74 6.39 6.99 7.64 
55-64 536 5.38 ** 1.10 3.07 4.00 4.72 5.38 6.06 6.83 7.46 
65-74 104 5.11 ** 1.26 2.01 3.53 4.49 5.10 5.76 6.58 7.74 
Ln HF (ms2) 35-44 982 
0.0000 
5.86 1.03 3.72 4.54 5.21 5.84 6.55 7.19 7.88 
45-54 1252 5.48 ** 1.08 3.17 4.12 4.77 5.55 6.20 6.84 7.51 
55-64 536 5.27 ** 1.02 3.31 4.00 4.64 5.30 5.92 6.51 7.32 
65-74 104 5.07 ** 1.29 2.58 3.58 4.22 5.01 5.88 6.85 8.14 
Comparisons between means performed by one-way ANOVA followed by Fisher’s LSD multiple 
comparisons. Significant differences against 35-44 age range: * - P<0.05. ** - P<0.01. 
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Figure 1. Exclusion criteria the sample. 
 
 
 
N=15,105  participants were recruted, and 
demographic and laboratorial data were colected
Electrocardiogram were performed 
and series R-R were pre-processed. 
13,214 participants were kept in this 
step.
Exclusions:
Chronic use of medication
(N=8,892) 
Cardiovascular or  cerebrovascular 
diseases
*myocardial infarction (N=278) 
*stroke (N=201)
*hypertension (N=5,363)
(blood pressure ≥140/90 mmHg)
Cardiac revascularization
N=268
Endocrine disorders
*body mass index ≥ 30 kg/m2 (N=3,464)
* diabetes mellitus
(glycaemia  ≥ 126mg/dL)
(N=2,970)
Kidney disease
creatinine ≥ 1.4 mg/dL for men (N=341)
and
creatinine ≥ 1.2mg/dL for women 
(N=130)
Common mental disorders
N=4,036
N=2,874 aparently health in the 
sample after all exclusions  
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Figure 2. Percentile curves of time domain HRV indices by sex in function of age. N=2,874. 
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Figure 3. Percentile curves of frequency domain HRV indices by sex in function of age. N=2,874.  
Indices were determined by AR method. 
 
